The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...

February is often celebrated as the month of love, but it's also recognized as American Heart Month, to raise awareness about cardiovascular health.

Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...

The six-day event will bring together thousands of transplant recipients, living donors and donor families to bring awareness ...

Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the ...

Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to educate others about the under-reported yet common disease.

BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...